1. Home
  2. SRRK vs AVNT Comparison

SRRK vs AVNT Comparison

Compare SRRK & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • AVNT
  • Stock Information
  • Founded
  • SRRK 2012
  • AVNT 1927
  • Country
  • SRRK United States
  • AVNT United States
  • Employees
  • SRRK N/A
  • AVNT N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • AVNT Major Chemicals
  • Sector
  • SRRK Health Care
  • AVNT Industrials
  • Exchange
  • SRRK Nasdaq
  • AVNT Nasdaq
  • Market Cap
  • SRRK 3.0B
  • AVNT 3.1B
  • IPO Year
  • SRRK 2018
  • AVNT 1993
  • Fundamental
  • Price
  • SRRK $39.23
  • AVNT $31.93
  • Analyst Decision
  • SRRK Strong Buy
  • AVNT Buy
  • Analyst Count
  • SRRK 9
  • AVNT 7
  • Target Price
  • SRRK $45.25
  • AVNT $47.43
  • AVG Volume (30 Days)
  • SRRK 2.7M
  • AVNT 536.9K
  • Earning Date
  • SRRK 11-11-2025
  • AVNT 11-05-2025
  • Dividend Yield
  • SRRK N/A
  • AVNT 3.32%
  • EPS Growth
  • SRRK N/A
  • AVNT 1.67
  • EPS
  • SRRK N/A
  • AVNT 1.29
  • Revenue
  • SRRK N/A
  • AVNT $3,254,800,000.00
  • Revenue This Year
  • SRRK N/A
  • AVNT $3.35
  • Revenue Next Year
  • SRRK $1,996.18
  • AVNT $3.88
  • P/E Ratio
  • SRRK N/A
  • AVNT $25.23
  • Revenue Growth
  • SRRK N/A
  • AVNT 3.28
  • 52 Week Low
  • SRRK $22.71
  • AVNT $27.86
  • 52 Week High
  • SRRK $46.98
  • AVNT $54.68
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 62.53
  • AVNT 34.95
  • Support Level
  • SRRK $34.52
  • AVNT $31.85
  • Resistance Level
  • SRRK $39.80
  • AVNT $33.18
  • Average True Range (ATR)
  • SRRK 2.58
  • AVNT 0.89
  • MACD
  • SRRK 0.59
  • AVNT -0.26
  • Stochastic Oscillator
  • SRRK 84.27
  • AVNT 3.13

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: